• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuramin

tetano

Editor, Senior Moderator
Protein Sci. 2015 Jun 5. doi: 10.1002/pro.2718. [Epub ahead of print]
[h=1]A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase.[/h] Phanich J[SUP]1[/SUP], Rungrotmongkol T[SUP]2,[/SUP][SUP]3[/SUP], Sindhikara D[SUP]4[/SUP], Phongphanphanee S[SUP]5[/SUP], Yoshida N[SUP]6[/SUP], Hirata F[SUP]7[/SUP], Kungwan N[SUP]8[/SUP], Hannongbua S[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The binding affinity of oseltamivir to the influenza B neuraminidase and to its variants with three single substitutions, E119G, R152K, and D198N, is investigated by the MM/3D-RISM method. The binding affinity or the binding free energy of ligand to receptor was found to be determined by a subtle balance of two major contributions that largely cancel out each other: the ligand-receptor interactions and the dehydration free energy. The theoretical results of the binding affinity of the drug to the mutants reproduced the observed trend in the resistivity, measured by IC[SUB]50[/SUB] ; the high-level resistance of E119G and R152K, and the low-level resistance of D198N. For E119G and R152K, reduction of the direct drug-target interaction, especially at the mutated residue, is the main source of high-level oseltamivir resistance. This phenomenon, however, is not found in the D198N strain, which is located in the framework of the active-site. This article is protected by copyright. All rights reserved.
? 2015 The Protein Society.


[h=4]KEYWORDS:[/h] 3D-RISM; Dehydration penalty; Influenza B virus; Neuraminidase; Oseltamivir resistance

PMID: 26044768 [PubMed - as supplied by publisher]
 
Back
Top Bottom